After a single administration of CAR-T, the enhancement of tumor luciferase signal was significantly decreased in the BxPC-3 model on days 14 and 21, indicating significant suppression of CEA++ pancreatic cancer growth due to CAR-T therapy. Here, CEACAM5 is linked to pancreatic neoplasm.